Company Mayinglong Pharmaceutical Group Co., LTD.

Equities

600993

CNE000001HN2

Pharmaceuticals

End-of-day quote Shanghai S.E. 03:30:00 15/05/2024 am IST 5-day change 1st Jan Change
29.9 CNY -2.38% Intraday chart for Mayinglong Pharmaceutical Group Co., LTD. +3.75% +23.66%

Business Summary

Mayinglong Pharmaceutical Group Co., Ltd. is a China-based company, principally engaged in pharmaceutical production, retailing and wholesaling businesses. The Company's pharmaceutical products are classified as drugs for hemorrhoid, including diosmin tablets, suppositories, pastes and granules, among others; drugs for cough, including levodropropizine oral solution and compound glycyrrhiza oral solution, as well as drugs for skin injuries, including products such as erythromycin ointment. The Company also provides specialty drugs. The Company is also engaged in the production and distribution of eye cream products with the brand named Mayinglong BaBao, as well as the provision of hospital clinical service. The Company distributes its products mainly in domestic markets.

Number of employees: 2,882

Sales per Business

CNY in Million2022Weight2023Weight Delta
Hemorrhoid Products
41.2 %
1,488 42.1 % 1,292 41.2 % -13.18%
Pharmaceutical
34.7 %
1,354 38.3 % 1,088 34.7 % -19.67%
Other Products
17.3 %
585 16.6 % 542 17.3 % -7.31%
Medical Services
11.0 %
259 7.3 % 345 11.0 % +33.28%
Internal Offset
-5.4 %
-189 -5.3 % -168 -5.4 % -10.76%
Other Business
1.2 %
35 1.0 % 38 1.2 % +9.08%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
99.9 %
3,530 99.9 % 3,133 99.9 % -11.26%
International
0.1 %
2 0.1 % 4 0.1 % +74.71%

Managers

Managers TitleAgeSince
Chief Executive Officer 46 -
Director of Finance/CFO 42 28/19/28
Chairman 59 -
Director/Board Member 38 19/21/19
Investor Relations Contact - -
Corporate Secretary 43 -

Members of the board

Members of the board TitleAgeSince
Chairman 62 01/01/01
Director/Board Member 38 14/22/14
Director/Board Member 60 13/23/13
Director/Board Member 48 14/22/14
Director/Board Member 38 19/21/19
Director/Board Member 42 28/19/28
Director/Board Member 42 14/22/14
Director/Board Member 52 14/22/14
Director/Board Member 58 28/19/28
Director/Board Member 57 19/21/19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 431,053,891 270,120,360 ( 62.67 %) 0 62.67 %

Shareholders

NameEquities%Valuation
129,918,181 30.19 % 499 M ¥
Wuhan State Owned Assets Sup. & Adm. Commssion
5.217 %
22,449,723 5.217 % 86 M ¥
Bank of Communications Schroder Fund Management Co., Ltd.
2.949 %
12,690,622 2.949 % 49 M ¥
Fu An Zhao
1.698 %
7,308,027 1.698 % 28 M ¥
Citic Securities Co., Ltd. (Invt Port)
1.230 %
5,290,800 1.230 % 20 M ¥
Zhong Ou Asset Management Co., Ltd
0.9349 %
4,022,757 0.9349 % 15 M ¥
China Southern Asset Management Co., Ltd.
0.7081 %
3,047,103 0.7081 % 12 M ¥
First-Trust Fund Management Co., Ltd.
0.6890 %
2,965,000 0.6890 % 11 M ¥
China Asset Management Co., Ltd.
0.6525 %
2,807,709 0.6525 % 11 M ¥
Caitong Securities Asset Management Co., Ltd.
0.5810 %
2,500,000 0.5810 % 10 M ¥

Company contact information

Mayinglong Pharmaceutical Group Co., Ltd.

No. 100 Zhoujiawan South Lake

430064, Wuhan

+

http://www.mayinglong.cn
address Mayinglong Pharmaceutical Group Co., LTD.(600993)
  1. Stock Market
  2. Equities
  3. 600993 Stock
  4. Company Mayinglong Pharmaceutical Group Co., LTD.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW